Comment & Response

Should Risk of Bias Be Assessed at the Outcome Level?

JAMA Oncology 10.1001/jamaoncol.2026.1484

May 28, 2026 at 11:00 AM EDT

Read the full article

Corresponding Author: Liang Yao, PhD, Lee Kong Chian School of Medicine, Nanyang Technological University, 11 Mandalay Rd, Singapore 308232 (liang.yao@ntu.edu.sg).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2026.1484?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=052826

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks